Recently, the significance of anthracosis in the tracheobronchial tree, lung parenchyma, and even non-respiratory organs has been postulated and discussed in association with other diseases, especially tuberculosis.
INTRODUCTION
Anthracosis is a term used to describe black pigmentation of the tracheobronchial tree involving both mucosal and submucosal layers and lung parenchyma, or black pigmentation in macrophages caused by the deposit of carbon, silica, and quartz particles (1) (2) (3) (4) . Thus, it is not a disorder, per se (5). It was first defined by Cohen in 1951 (6). If anthracosis is associated with mucosal proliferation resulting in luminal obliteration and/or obstruction, it refers to the condition anthracofibrosis, which was first described by Chung et al. in 1998 (7). There have been TANAFFOS other synonyms for these conditions, including anthracotic bronchitis, anthracostenosis that first used by Törün et al.(8) specifically for patients with a history of long-term exposure to biomass smoke (9) , and bronchial anthracosis (10) . Given the widespread clinical manifestations and the histopathological, radiological, and bronchoscopic findings discussed in this study, we assume that the black pigmentations would cause deposits to form in multiple organs. Thus, it is more appropriate to consider this condition "ANTHRACOSIS SYNDROME".
Anthracosis is an ancient disease, reported even in mummies (11) . However, recently, there has been an interest in recognizing its clinical significance, as anthracosis is often an incidental finding during bronchoscopic evaluation of patients with non-specific clinical symptoms such as cough, dyspnea, phlegm, and wheezing (12) . On the other hand, anthracofibrosis may be indicative of a chronic disease of both the tracheobronchial tree and lung (13) .
Here, we reviewed the current information on anthracosis and anthracofibrosis, including epidemiology, etiology, pathogenesis, clinical manifestation, and natural course, associated conditions, mediastinal lymphadenopathy, cancer susceptibility, lung parenchymal involvement, bronchopneumonia susceptibility, other organ involvement, diagnosis method, and finally, prevention and treatment.
display symptoms (18, (23) (24) (25) . In both Korean and Iranian rural homes, the kitchen is a place for cooking and heating using biomass fuels such as wood, leaves, and crop residues. In this setting, ventilation is almost always restricted to a single window on the roof, resulting in inadequate air circulation. This housing condition and lifestyle are often the same in studies reporting BAF in other countries (18) . Previous studies have revealed that cooking smoke is associated with a higher risk of chronic lung diseases. Although there are limited data on patients with BAF in developed countries, some cases of BAF have been reported. These patients were immigrants to North
America from developing countries such as India, where biomass fuel had been used (18, 26, 27) .
A study published in 2010 reported that BAF with associated pulmonary tuberculosis (PTB) was common in immigrants to Canada from the Indian subcontinent (28) . In this study involving 61 patients of foreign origin with PTB, 10 (16.7%) were diagnosed with BAF; nine of these patients were from the Indian subcontinent and one was from Vietnam. As with previous studies, the majority of patients were females, with a mean age of 69.8 ± 9.3 years (15) .
These data suggest that most patients diagnosed with anthracotic bronchitis are non-smoking elderly women living in a rural setting who have had no relevant occupational history for anthracosis (29, 30) .
Etiology:
The In conclusion, it seems that anthracofibrosis has an important relationship with pulmonary tuberculosis, either as a coexisting condition or a causative factor. Thus, the presence of TB should always be investigated when anthracofibrosis is present.
Pathogenesis:
The exact pathogenesis of anthracofibrosis is still a 
Clinical Manifestation:
Most patients with anthracosis present with dypnea (90% -100% of cases) and cough (in 29.8% -83.6% of cases) (15) . Hemoptysis, or non-specific chest pain, constitutional symptoms, and sputum production -both black and watery -are observed less frequently. These symptoms vary in frequency between studies (10, 19, 21, 49, 50) . New onset weight loss or fever (51), enlarged mediastinal lymph nodes, and subsequent complications such as vocal cord paralysis (52) or broncholithiasis (45) may be the symptoms initially observed in anthracofibrosis patients.
The most common symptom associated with pulmonary auscultation in patients with anthracosis is wheezing (7); rales or decreased breathing sounds are noted less frequently (32) . Normal physical examination is noted in some cases but the exact prevalence is unclear (19) . One possible explanation for this variation may be the association of anthracofibrosis with other diseases, resulting in altered clinical features for some patients.
Natural course:
The course of anthracofibrosis is chronic, and it is commonly misdiagnosed as chronic bronchitis. Most patients with bronchial anthracotic lesions had a stationary and inactive course that might be interrupted by acute attacks (20) . 
Associated conditions:
Although some studies report a strong association between anthracofibrosis and TB, Park et al. (41) 
Cancer susceptibility:
Cigarette smoke is a definitive cause of lung cancer. Gunbatar et al. (58) has also shown that biomass-smoke exposure is an important risk factor in human lung cancer.
Gold et al. (27) proposed that cooking in a poorly ventilated atmosphere may produce high levels of BaP, equal to that in packs of cigarettes a day. In another study, 
Bronchopneumonia susceptibility:
It could be that bronchopneumonia is prevalent in anthracotic patients due to bronchial narrowing, which leads to poor drainage of secretions and predisposes the patient to recurrent infections (68), but Singh et al. did not find a significant association between bronchopneumonia and anthracosis in their study population (10) .
On the other hand, Cho et al. reported a high incidence of pneumonia in up to 40% of anthracotic patients and opined that the location of pneumonic consolidation on a CXR is often consistent with lobes that have bronchial narrowing. Thus, bronchial anthracofibrosis may be a major risk factor for pneumonia (69) .
Additional organ involvement:
Anthracosis may affect other organs in the body, as there are reports of liver and spleen involvement. As calcification is a radiographic sign of the disease,
Mirsadraee et al. have recommended considering
anthracosis among the possible diagnoses when presented with high-attenuation images from all parts of the body.
The diagnosis should be confirmed using histopathological evaluation(13).
Concomitant esophageal anthracosis:
Esophageal anthracosis is a rare disease. Yang et al. 
Lung parenchymal involvement:
In 
Diagnosis:
The definitive diagnosis of anthracofibrosis is usually achieved during a bronchoscopic examination of patients with chronic cough, sputum, and dyspnea (9).
Pulmonologists should consider the possibility of this disease, especially in older, non-smoking women exposed to biomass combustion products. Sputum samples should be taken for acid-fast bacilli smear and culture, and, if TB is confirmed, the proper treatment with radiographic followup should be initiated (28) .
Pathology:
Amoli ( of their study group. In that study, the diffusing capacity of the lungs was reported to be normal in all patients, which ruled out emphysema. Authors rationalized that the high frequency of obstructive pattern in their study to be due to the inclusion criteria set for patient enrollment, as they allowed entrance of patients only with anthracofibrosis. The Korean studies and Amoli's study, on the other hand, enrolled every subject with black discoloration and without bronchial deformity (14, 20, 56, 57) .
Respiratory function tests

Radiology:
Radiological abnormalities are discovered in the CXRs and CT scans of almost all anthracosis and anthracofibrosis cases. Recently, a few studies reported that atelectasis, along with mediastinal lymph-node calcification, is a radiological sign for anthracofibrosis, but a main limitation to these studies was the lack of a control group for statistical analysis (13).
Mirsadraee et al. tried to overcome this limitation by
performing a prospective, case-control study including three groups of 70 patients with a bronchoscopic diagnosis of simple anthracosis and anthracofibrosis and 40 patients with a non-anthracotic diagnosis as control group. In this study, in both simple anthracosis and anthracofibrosis, lymph-node and bronchial calcifications proved to be the most significant radiological findings. The odds ratio of lymph-node calcification was 22.9 in anthracosis, with 83% sensitivity and 89% specificity. They also reported bronchial calcification as a useful finding, as it had an odds ratio of 9.4 for anthracofibrosis (13) .
In this regard, the third most-common radiological finding in anthracosis/anthracofibrosis patients was a benign mass with or without calcification. Other radiological findings noted at a lower frequency included collapse, bronchial stenosis, and collapse consolidation In conclusion, the possibility of benign conditions should be considered when intense uptake is observed on a PET scan in hilar and mediastinal lymphadenopathy, especially when there is a history of exposure to known risk factors (29) .
Bronchoscopy:
Currently, the diagnosis of anthracosis is mostly made 
Diagnosis of TB in anthracosis patients:
Clinical symptoms such as cough, hemoptysis, and 
Prevention and Treatment:
There is no specific treatment for anthracofibrosis, and 
